Skip to main content
Top
Published in: International Cancer Conference Journal 4/2018

01-10-2018 | Case report

Two case reports of fair lower limb function after sciatic nerve sacrifice for the treatment of a malignant peripheral nerve sheath tumor

Authors: Akiyoshi Shimatani, Masanari Aono, Manabu Hoshi, Naoto Oebisu, Tadashi Iwai, Naoki Takada, Hiroaki Nakamura

Published in: International Cancer Conference Journal | Issue 4/2018

Login to get access

Abstract

Wide resection for malignant soft tissue tumors may require resection of a major nerve. When a limb salvage procedure is selected in these cases, the anticipated functional outcome of the procedure must be clearly discussed with the patient, as recovery of normal function cannot be expected. In this report, we describe our surgical management of two cases of malignant peripheral nerve sheath tumor, a 58-year-old man and a 10-year-old girl, requiring a limb salvage procedure with sacrifice of the sciatic nerve. Although both patients required a short-leg brace for walking, because of a drop foot, both patients reported satisfactory functional results and were able to perform their activities of daily living with only slight difficulties. Based on our experience, limb salvage surgery can be considered for the treatment of malignancies involving the sciatic nerve, with fair functional outcomes expected.
Literature
1.
go back to reference Enneking WF, Dunham W, Gebhardt MC et al (1993) A system for functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286:241–246 Enneking WF, Dunham W, Gebhardt MC et al (1993) A system for functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286:241–246
2.
go back to reference Ng VY, Scharschmidt TJ, Mayerson JL et al (2013) Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions. Anticancer Res 33:2597–2604PubMed Ng VY, Scharschmidt TJ, Mayerson JL et al (2013) Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions. Anticancer Res 33:2597–2604PubMed
4.
go back to reference Porter DE, Prased V, Foster L et al (2009) Survival in malignant peripheral nerve sheath tumors: a comparison between sporadic and neurofibromatosis type-1 associated tumors. Sarcoma 2009:756395CrossRefPubMedPubMedCentral Porter DE, Prased V, Foster L et al (2009) Survival in malignant peripheral nerve sheath tumors: a comparison between sporadic and neurofibromatosis type-1 associated tumors. Sarcoma 2009:756395CrossRefPubMedPubMedCentral
6.
go back to reference Hohenberger P, Allenberg JR, Schlag PM et al (1999) Results of surgery and multimodal therapy for patients with soft tissue sarcomas invading to vascular structures. Cancer 85:396–408CrossRefPubMed Hohenberger P, Allenberg JR, Schlag PM et al (1999) Results of surgery and multimodal therapy for patients with soft tissue sarcomas invading to vascular structures. Cancer 85:396–408CrossRefPubMed
7.
go back to reference Spiro IJ, Rosenberg AE, Springield D et al (1995) Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience. Cancer Invest 13:86–95CrossRefPubMed Spiro IJ, Rosenberg AE, Springield D et al (1995) Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience. Cancer Invest 13:86–95CrossRefPubMed
8.
go back to reference Williard WC, Hajdu SI, Casper ES et al (1992) Comparison of amputation with limb sparing operations for adult soft tissue sarcoma of extremity. Ann Surg 215:269–275CrossRefPubMedPubMedCentral Williard WC, Hajdu SI, Casper ES et al (1992) Comparison of amputation with limb sparing operations for adult soft tissue sarcoma of extremity. Ann Surg 215:269–275CrossRefPubMedPubMedCentral
9.
go back to reference Nambisan RN, Rao U, Moore R et al (1984) Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol 25:268–272CrossRefPubMed Nambisan RN, Rao U, Moore R et al (1984) Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol 25:268–272CrossRefPubMed
10.
go back to reference Fuchs B, Davis AM, Wunder JS et al (2001) Sciatic nerve resection in the thigh.: a functional evaluation. Clin Orthop Relat Res 382:34–41CrossRef Fuchs B, Davis AM, Wunder JS et al (2001) Sciatic nerve resection in the thigh.: a functional evaluation. Clin Orthop Relat Res 382:34–41CrossRef
11.
go back to reference Davis AM, Devlin M, Griffin AM et al (1999) Functional outcome in amputation versus limb-sparing of patients with lower extremity sarcoma. Arch Phys Med Rehabil 80:615–618CrossRefPubMed Davis AM, Devlin M, Griffin AM et al (1999) Functional outcome in amputation versus limb-sparing of patients with lower extremity sarcoma. Arch Phys Med Rehabil 80:615–618CrossRefPubMed
12.
go back to reference Jacob Bickels JC, Witting Y, Kollender et al (2002) Sciatic nerve resection. Clin Orthop Relat Res 399:201–204CrossRef Jacob Bickels JC, Witting Y, Kollender et al (2002) Sciatic nerve resection. Clin Orthop Relat Res 399:201–204CrossRef
Metadata
Title
Two case reports of fair lower limb function after sciatic nerve sacrifice for the treatment of a malignant peripheral nerve sheath tumor
Authors
Akiyoshi Shimatani
Masanari Aono
Manabu Hoshi
Naoto Oebisu
Tadashi Iwai
Naoki Takada
Hiroaki Nakamura
Publication date
01-10-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 4/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0338-x

Other articles of this Issue 4/2018

International Cancer Conference Journal 4/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine